l 663581 has been researched along with devazepide in 1 studies
| Studies (l 663581) | Trials (l 663581) | Recent Studies (post-2010) (l 663581) | Studies (devazepide) | Trials (devazepide) | Recent Studies (post-2010) (devazepide) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 780 | 5 | 42 |
| Protein | Taxonomy | l 663581 (IC50) | devazepide (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.0009 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
| Cholecystokinin receptor type A | Homo sapiens (human) | 0.0002 | |
| Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.245 | |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | 0.27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, JH; Lin, TH | 1 |
1 other study(ies) available for l 663581 and devazepide
| Article | Year |
|---|---|
Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Blood-Brain Barrier; Brain; Devazepide; Diabetes Mellitus, Experimental; Diazepam; Kidney Diseases; Liver Diseases; Male; Phenylurea Compounds; Protein Binding; Rats; Rats, Inbred Strains; Serum Albumin | 1990 |